Advisory Alpha’s Bristol-Myers Squibb BMY Stock Holding History

Advisory Alpha's BMY Position: Q2 2026 in Review

Advisory Alpha reduced its Bristol-Myers Squibb (BMY) stake by 13% in Q2 2026, selling an estimated $57K and leaving 6,527 shares worth $376K. The position accounts for 0.01% of the portfolio, ranked #426.

Advisory Alpha first reported a position in BMY in Q1 2019 and has held it in 21 quarters since. The position peaked at $581K in Q1 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

• Advisory Alpha held 6,527 shares of Bristol-Myers Squibb worth $376K as of Q2 2026.
• Advisory Alpha sold 993 Bristol-Myers Squibb shares in Q2 2026, an estimated $57K.
• Bristol-Myers Squibb made up 0.01% of Advisory Alpha's portfolio in Q2 2026, its #426 holding.
• Advisory Alpha first reported a position in Bristol-Myers Squibb in Q1 2019 and has held it in 21 quarters since.
• Advisory Alpha's Bristol-Myers Squibb position peaked at $581K in Q1 2025.
• 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Advisory Alpha's 13F filing for Q2 2026, filed 11 Aug 2026.